WCAS Sells its Stake in Humana's Senior Primary Care Clinics

StrangeTony,

The curse that is financial rapscallion WCAS may be leaving Humana.  Former Humana CEO Bruce Broussard cut his teeth at U.S. Oncology under WCAS ownership.  He arranged the deal that gave majority interest in our Gentiva hospice site to WCAS and TPG in summer 2018.  

Humana bought out WCAS' and TPG's stakes in Gentiva Hospice in 2021 but later flipped that share to another financial rapscallion CDR (Clayton, Dubilier and Rice) in August 2022.  At least that's what I thought.  

This is from an SEC filing made in February 2026.

The CenterWell segment also includes our strategic partnerships with Welsh, Carson, Anderson & Stowe, or WCAS, to develop and operate senior-focused, payor-agnostic, primary care centers, as well as our minority ownership interest in hospice operations.

WCAS still had a minority interest in hospice operations at the end of 2025? 

Humana jettisoned the rest of Gentiva to BlackRock and a "consortium of investors" in June.  WCAS could still be in the consortium.  

Tom Scully, WCAS General Partner and former Medicare/Medicaid Chief, likely had his hands in the deal that moved senior primary care clinics from his firm's ownership to BlackRock's HPS Investments at a price of $2.8 billion.

WCAS funded Humana's senior primary care clinics in two rounds, a $600 million round in 2020 (which may have expanded to $800 million) and a $1.2 million round in 2022.  

An $800 million (40%) to $1 billion (55%) profit is substantial and does not help healthcare costs go down.  It does make Tom Scully and his fellow financial rapscallions much richer and that seems to be what our healthcare non-system is all about.  

Anonymous